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Summary Trends in incidence and mortality for basal cell carcinomas (BCC), squamous cell carcinomas
(SCC) and cutaneous malignant melanoma (CMM) for the period 1976-92 were analysed using data from the
Cancer Registry of the Swiss Canton of Vaud. Among the 12473 cases registered, 63% were basal cell
carcinomas, 25% squamous cell cancers, 9% cutaneous malignant melanomas and 3% other miscellaneous
histological types. Age-standardised incidence rates increased substantially for all histological types considered,
from 44% increase for BCC in males to a more than 3-fold increase for SCC in females, with only signs of a
levelling off in 1991-92, following a peak of incidence rates in 1986-90. From 1976-80 to 1991-92 CMM
incidence increased by approximately 80% in both sexes. In 1991-92, age-standardised (world) incidence rates
per 100 000 were 69.3 for basal cell, 29.1 for squamous cell cancers and 11.5 for melanomas in males, and,
respectively, 62.2, 18.0 and 12.3 in females. With respect to mortality, in males rates increased for both
non-melanocytic cancer (>40%) and CMM (>53%) whereas in females CMM, BCC and SCC rates
remained approximately stable over the calendar periods examined. In 1991-92, age-standardised mortality
rates per 100 000 were 2.6 for melanoma and 0.7 for other skin cancers in males, and, respectively, 1.6 and 0.2
in females. Upward trends in incidence were also present, and relatively homogeneous across, various age
groups examined. However, SCC and CMM levelled off over the last period, and some decline was apparent
in males below age 45. Separate analysis by anatomical site showed substantial increases in the head and neck
for SCC and BCC, and in the trunk for CMM. In 1991-92, middle-aged women had almost equalled male
incidence rates of BCC and SCC. A female excess of CMM incidence seemed to have disappeared since
1981-86. The increase in skin cancer incidence thus continued in this population up to the late 1980s, with a
plateau only after 1990.
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The analysis and interpretation of temporal trends for skin
cancer is hampered by difficulties in data collection and
interpretation to a larger extent than for most other cancer
sites or types. The first problem stems from the coexistence
of at least three main histotypes of skin cancer; basal cell
carcinoma (BCC), squamous cell carcinoma (SCC), and
cutaneous malignant melanoma (CMM), substantially
differing from each other from an epidemiological and
clinical viewpoint. At the level of death certificates, however,
the distinction between the three types of skin cancer is
largely unsatisfactory (Percy et al., 1981). Population-based
sources of incidence also present weaknesses ranging from
explicit exclusion of skin cancer from certain cancer registra-
tion schemes (Parkin et al., 1992) to various degrees of
under-notification (Koh et al., 1993) and multiple registration
(Young et al., 1981). Finally, a large proportion of skin
cancers, most notably BCC (Harvey et al., 1989; Burton and
Armstrong, 1994), is almost invariably non-fatal, and often
treated with out-patient procedures. Incidence rates are thus
likely to be heavily influenced by the extent to which people
seek medical advice and the skin lesion undergoes surgical
resection and histological examination. All these circum-
stances tend to exaggerate upward trends and, anyhow, make
international comparisons difficult.
These factors notwithstanding, several reports of upward
trends in mortality and incidence rates of CMM, BCC, SCC
and other skin neoplasms have been published, especially
from the Australasian Continent (Giles et al., 1989; Brown
and Palmer, 1991; Cooke, 1992; Jones et al., 1992; McCredie
et al., 1992; MacLennan et al., 1992; Burton et al., 1993), the
US (Glass and Hoover, 1989; Ries et al., 1991; Dennis et al.,
1993), and Europe (Levi et al., 1988; Osterlind et al., 1988;
Magnus, 1991; Mackie et al., 1992; Nelemans et al., 1993),
including southern Europe (Franceschi et al., 1992; Pollan
and Lopez Abente, 1993; Franceschi et al., 1994). Data on
time trends in the occurrence of BCC and SCC, especially
population-based data, are much scantier (Levi et al., 1988;
Gallagher et al., 1990; Coebergh et al., 1991; Magnus, 1991;
Kaldor et al., 1993; Marks et al., 1993).
The present study took advantage of a population-based
registration system which includes non-melanocytic skin
cancer and has been operating since 1976. It was, therefore,
possible to update a published population-based series of
skin cancer cases (Levi et al., 1988) up to 1992. A particular-
ly favourable environment for skin cancer registration has
long been present in this population, since in this region,
traditionally, the large majority of cutaneous lesions sur-
gically resected are examined by a pathologist. Thus,
previous reports from this series (Levi-atir Chapallaz, 1981;
Levi et al., 1988) have been frequently quoted as standard
reference figures (Lee, 1982; Giles et al., 1988). This allows a
detailed analysis of time trends of both incidence and mor-
tality of BCC, SCC and CMM, including separate analyses
of sexes, various age groups and anatomical subsites.
Materials and methods
The data were abstracted from the Vaud Cancer Registry file,
which includes information concerning incident cases of
malignant neoplasms in the Canton (whose population,
according to the 1990 Census, was about 580 000 inhabitants;
Levi et al., 1992). Information collected by the register
includes general demographic characteristics of the patient
(age, sex, municipality of residence), site and histological type
of the tumour according to the standard International
Classification of Diseases for Oncology (WHO, 1976), and
time of diagnostic confirmation.
The present series comprises 12095 incident skin cancer
primaries (6171 males and 5924 females) registered from 1976
to 1992 in the population of the Swiss Canton of Vaud. All
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Table I Distribution of 12 095 incident casesa and 353 deathsbc from skin cancer in Vaud, Switzerland, according to histological type, calendar
period and sex, 1976-92
Males Females
Incident cases Deaths Incident cases Deaths
Histological type 1976-80 1981-85 1986-90 1991-92 Total total 1976-80 1981-85 1986-90 1991-92 Total total
Basal-cell carcinoma 893 1086 1350 613 3942 17 817 1042 1339 690 3888 14
Squamous-cell carcinoma 288 399 733 287 1707 30 175 315 634 254 1378 31
Cutaneous malignant 96 133 200 93 522 137 138 160 253 107 658 124
melanoma
Total 1277 1618 2283 993 6171 184 1130 1517 2226 1051 5924 169
aSource ofincidence data: Vaud Cancer Registry (378 skin cancer cases whose histological type was other or unspecified were not considered).
bSource ofmortality data: Swiss Federal Statistical Office.cSkin cancers other than basal- or squamous-cell carcinomas, and malignant melanoma,
according to the Vaud Cancer Registry datafile, were not considered.
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Figure 1 Trends in age-standardised (world standard population) incidence per 100000 for skin cancer cases from the Vaud
Cancer Registry, Switzerland, according to histological type, sex and age group, 1976-92. 0- 0----, basal cell; + +,
squamous cell; *- -*, malignant melanoma.
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vcases were histologically verified. As a rule, multiple skin
tumours (either synchronous or metachronous) are classified
by the site of the first recognised tumour of the same mor-
phological type. For the present report, cases were grouped
into the following three morphological categories: (1) basal
cell (ICD-O M: 8090-8095); (2) squamous cell (ICD-O M:
8070-8076; and (3) malignant melanoma (ICD-O M: 8720-
8790, excluding 8742.2, lentigo maligna, but including 8742.3
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lentigo maligna melanoma). Anatomical subsite of cancer
occurrence could be precisely notified to the Registry (ICD-O
T: 173.0-173.7) in 98% of the cases. Cincers whose his-
tological type was other or unspecified (n = 378, 3.8%) were
not considered. Furthermore, cancers arising from skin of
genital organs [e.g. labia majora or minora, vulva, penis or
scrotum (ICD-O T: 184, 187)] were excluded from the pres-
ent report.
Table II Age-standardised (world standard population) incidencea and mortalitybc rates per 100 000 for skin cancer from the Vaud population,
Switzerland, according to histological type, sex and period, 1976-92
Males Females
SCC BCC SCC & BCC CMM SCC BCC SCC & BCC CMM
Years Incidence Incidence Mortalityc Incidence Mortality Incidence Incidence Mortalityc Incidence Mortality
1976-80 14.2 48.1 0.5 5.8 1.7 5.8 34.1 0.2 6.8 1.5
1981-85 18.2 55.7 0.5 7.4 1.8 9.9 42.1 0.5 7.7 1.3
1986-90 31.7 65.6 0.7 10.7 2.3 19.9 50.1 0.3 11.8 1.7
1991-92 29.1 69.3 0.7 11.5 2.6 18.0 62.2 0.2 12.3 1.6
Change (%) + 105 + 44 + 40 + 98 + 53 + 210 + 82 0 + 81 + 7
Average change + 6.3* + 2.6* + 7.0 NS + 5.4** + 3.1 NS + 9.0* + 4.2** -3.5 NS + 5.3** + 1.5 NS
per year (%)
aSource ofincidence: Vaud Cancer Registry. bSource ofmortality: Swiss Federal Statistical Office.cSkin cancers other than basal or squamous cell
carcinomas or malignant melanoma, according to the Vaud Cancer Registry datafile, were not considered.
SCC, squamous cell carcinomas; BCC, basal cell carcinomas; CMM, cutaneous malignant melanomas.
*P<0.01, **P<0.001, NS, statistically non-significant.
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Figure 2 Trends in age-specific incidence rates per 100 000 from 40-49 to 80-89 years ofbasal cell, squamous cell carcinomas and
malignant melanomas plotted against the central year of birth cohort in males and females, 1976-92. (The points corresponding to
the same age group are joined in the graphs so that the cohort effect can be read in the ordinate.)
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All deaths from skin cancer (melanocytic, non-melano-
cytic) certified by the Swiss Federal Statistical Office in the
Vaud population, and originally classified according to the
standard International Classification of Diseases (ICD),
Eighth Revision (172-3), were cross-checked through the
Vaud Registry datafile.
Age-specific (15-44, 45-64, 65 years and over) as well as
overall age-standardised incidence and mortality rates (world
standard population) were computed. Trends in incidence
over time were estimated using linear regression of
logarithms of age-standardised rates for each histological
subtype.
Results
The distribution of 12095 incident cases of skin cancers
registered in the Vaud Cancer Registry over the period
1976-92 according to histological type, calendar period and
sex is given in Table I. Overall, there were 7830 (65%) BCC
(3942 in males, 3888 in females), 3085 (26%) SCC (1707 in
males, 1378 in females) and 1180 (10%) CMM (522 in males,
658 in females).
A total of 353 deaths from skin cancer occurred in the
period 1976-92 in the Vaud population, and their distribu-
tion by histological type (i.e. melanocytic and non-
melanocytic skin cancer) and sex is also given in Table I. Of
the 353 deaths, 261 (74%, 137 in males and 124 in females)
were from CMM, 61 (17%, 30 in males and 31 in females)
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Figure 3 Trends in age-standardised (world standard popula-
tion) mortality per 100 000 for melanocytic skin cancer cases
from the Canton of Vaud, Switzerland, according to sex and age
group, 1976-92. (a) Males. (b) Females. 0-----0, 15-44
years; 0- - - -- -0, 45-64 years;
* *, >65 years;
+ +, all ages.
from SCC, and 31 (9%, 17 in males and 14 in females) from
BCC.
Age-standardised incidence and mortality rates in three
subsequent quinquennia (1976-80, 1981-85, 1986-90) and
for the last 2 years are given in Table II, separately for SCC,
BCC and CMM and the two sexes. Incidence rates increased
substantially over the examined period for all the histological
types, ranging from a 44% increase for BCC in males to a
more than 3-fold increase for SCC in females. An elevation
of approximately 80% was seen from 1976-80 to 1986-90
for CMM incidence in both sexes. For SCC and CMM, in
both sexes there were signs of levelling off in 1991-92 after
the peak reached in 1986-90. In 1991-92, age-standardised
(world) incidence rates per 100000 were 69.3 for basal cell,
29.1 for squamous cell cancers, and 11.5 for melanomas in
males and, 62.2, 18.0 and 12.3, respectively, in females.
Over all the examined period the increases in rates ranged
between 2.6% per year for BCC incidence in males to 9.0%
per year for SCC incidence in females. Yearly increases of
CMM were slightly greater than 5% in both sexes.
Mortality rates could be examined for the combination of
SCC and BCC, and CMM (Table II). In males, mortality
rates increased from 1976-80 and 1990-92 for both non-
melanocytic cancer (>40%) and CMM (>53%), albeit to a
lower extent than incidence rates. Conversely, in females,
mortality rates for CMM and SCC and BCC combined were
stable over the periods examined. In 1991-92, age-
standardised mortality rates per 100000 were 2.6 for
melanoma and 0.7 for other skin cancers in males, and, 1.6
and 0.2 in females.
Age-standardised and age-specific incidence rates of SCC,
BCC and CMM by calendar period ofdiagnosis were plotted
in Figure 1. The upward trends were relatively homogeneous
in the two sexes across the three age groups examined.
Age-specific rates, but especially those in subjects below age
65, suggest that the incidence of SCC and CMM levelled off
over the last period considered. Only in males below age 45
some decline for BCC and SCC was evident over the most
recent calendar period. A notable exception is the steady rise
of basal cell cancer above age 65 for both sexes.
Cohort-specific analyses of incidence of BCC, SCC and
CMM are plotted in Figure 2. For basal cell carcinomas,
steady upward trends were observed in more recent genera-
tions for both sexes, although the rises were greater in
females, whose rates were higher than for males over the
most recent cohorts. The pattern of increasing incidence
across subgequent generations was even more consistent for
SCC, since in both sexes rates for the more recent genera-
tions were 2- to 4-fold higher than for cohorts born two
decades earlier. As for BCC, the rises were greater in females
than in males. With reference to CMM, in contrast, the
upward trends were larger in males than in females who,
already, showed higher rates at the beginning of the observa-
tion.
The limited numbers of deaths from non-melanocytic skin
cancer prevent a meaningful analysis of trends of mortality
rates in specific age groups. Figure 3 is restricted, therefore,
to the changes of mortality rates in CMM, by sex, overall
and in three separate age groups. It is, thus, clear that
upward mortality trends were seen in middle-aged men
(>25%). In elderly men, after a rise by over 2-fold between
1976 and 1985, mortality remained relatively stable. Con-
versely, in females, apart from a 2-fold increase in mortality
rates of CMM below age 45 years, some decline was evident
in the elderly.
Sex-specific trends in skin cancer incidence for four
different anatomical sites are shown in Figure 4. Upward
trends were observed for both sexes and various sites. Sub-
stantial increases were found in the head and neck for SCC
and BCC, but in the trunk for CMM. The largest relative
increase was recorded in the upper limbs (including
shoulders) for non-melanocytic cancer and, again, in the
trunk for CMM.
Changes in the male-to-female ratios of all age-standard-
ised incidence rates from 1976-80 to 1990-92 are considered
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.in Figure 5. In 1991-92 middle-aged women had almost
equalled incidence rates of men with respect to BCC. The
male-to-female ratio remained similar and close to unity with
respect to CMM, with the possible exception of the elderly,
where a female excess of CMM incidence seemed to be
disappearing already in the early 1980s.
Discussion
The present 17 year population-based study of skin cancer in
the Canton of Vaud allows one of the few long-term evalua-
tions of trends of different types of skin cancer published so
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far. An increase in overall skin cancer incidence, already
reported for the period 1976-85 (Levi et al., 1988), persisted
up to 1990 for all skin cancer types, with some hints of a
plateau of incidence rates only after 1990, especially in males
and with respect to SCC.
The upward trends for non-melanocytic skin cancer are
consistent with those reported between 1970 and 1985 in
eight out of 13 populations for which incidence data over this
period were available (Parkin et al., 1992). Incidence in-
creases were also documented, separately for BCC and SCC,
in a few other populations, based on either cancer registra-
tion schemes (Giles et al., 1989; Coebergh et al., 1991; Mag-
nus, 1991; Kaldor et al., 1993), household national surveys
(Fears and Scotto, 1982; Marks et al., 1993) or health plans
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Figure 4 Trends in age-standardised (world standard population) incidence per 100 000 for skin cancer cases from the Vaud
Cancer Registry, Switzerland, according to histological type, sex and anatomical site, 1976-92. 0- - --0, basal cell;
+ +, squamous cell; *- -*, malignant melanoma.
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*k change in CMM mortality in the same period, led to the
formulation of the hypothesis that the widespread screening
for CMM has uncovered in many areas of the developed
- -|--- *-... world a form of the disease that manifests as thin melanoma,
_________________________ _ and does not frequently progress or metastasise (Burton and
Armstrong, 1994).
0-.-------. ................................... ........ The examination of mortality rates, albeit based for non-
- - - - __ ~ ~ ~ ^^^melanocytic (SCC and BCC) cancer on small number of
deaths, can help quantify the public health importance of the
rise in skin cancer. The concern for inaccuracies of death
certificates with respect to the distinction ofSCC and BCC,
76 81 86 91 96 on one side, and CMM on the other, is attenuated by the
validity checks made possible by the linkage matching within
b the Vaud Cancer Registry datafile, and the presence of con-
sistent mortality increases for various types of skin cancer.
Both types showed moderate mortality increases in men, but
.-.-._ ...~. .. stable patterns in females. The present data are thus in
' = - .--. _ agreement with those from the US, where mortality rates
from non-melanocytic skin cancer had fallen considerably
, -8' -* .between 1950 and 1980, but have begun to increase in men
thereafter (Glass and Hoover, 1989; Ries et al., 1991).
Conversely, no reversal in the long-term increases in CMM
mortality (Roush et al., 1992; Nelemans et al., 1993) was
.____________________________________ observed in the Canton of Vaud. This finding is consistent
76 81 86 91 96 with mortality data from Spain (Pollan and Lopez-Abente,
C 1993) and other European countries (Franceschi et al., 1991).
While the examination of incidence rates of non-
melanocytic skin cancer in the young is hampered by the
rarity of the disease in this age group, the excess increase in
BCC and, most notably, SCC in females, as compared with
- ~ males, was seen consistently in middle-aged as well as elderly ..............
...... ° ;.'.-'.'.--..n_............ individuals. SCC cancer was approximately 2-fold more fre-
- - - - - ~ quent in males than females in 109 out of 120 registries
-~~~~ - reporting skin cancer incidence rates, the only exception
being found in some dark-skinned populations (Parkin et al.,
1992). However, the present data suggest that male and
female incidence rates of SCC are progressively approaching 76 81 86 91 96 each other (since the ratio declined from 2.4 in 1976-80 to
Calendar period 1.6 in 1991-2) and are comparable in middle-aged men and
women in the last examined period. Thus, the male-to-female 5 Trends in age-standardised (world standard popula- rai of iniec is loer intepeetdtst'hni
ex ratios for skin cancer cases from the Vaud Cancer
y, Switzerland, according to histological type and age other populations (Coebergh et al., 1991; Magnus, 1991;
1976-92. (a) Basal cell carcinoma. (b) Squamous cell Kaldor et al., 1993; Marks et al., 1993) where, however,
ma. (c) Malignant melanoma. 0-----0, 15-44 years; larger increases have also been recorded in women than in
-, 45-64 years; + +, 65 years; men in the last decade (Kaldor et al., 1993; Marks et al.,
-+, all ages. 1993).
With respect to specific anatomic sites, the largest relative
increases occurred in the upper limbs for non-melanocytic
cancer and in the trunk for CMM in both sexes. As from
previous observations (Levi et al., 1988; Kaldor et al., 1993),
Lnd Hoover, 1989). On account of the aforementioned relatively low BCC/SCC and, even more, BCC/CMM ratios
l(e.g. underreporting and variations in cancer ascer- emerged in areas most heavily exposed to the sun, including
it over time), various methods have different strengths not only the head and neck but also the upper limbs and
rtcomings in the evaluation of skin cancer incidence, lower limbs. The occurrence of SCC in the trunk remains a
r a reasonably consistent picture (Giles et al., 1989; rare event with, however, some tendency to increase.
et al., 1993). It is nonetheless difficult to quantify With respect to possible inferences on the effect of sun
ich of the apparent increase in the present study is exposure on cancer risk, the relatively similar rises of SCC
improved registration, although there were no and CMM, most notably in the upper limbs in females and
tic changes in the criteria and methodology adopted lower limbs in both sexes, support a role for increasing
ording skin cancer over the study period. cumulative sun exposure, rather than implicating a differ-
ncreases in incidence rates of CMM in both sexes ential effect of total accumulated exposure or intermittent
J in this Swiss population are in agreement with intense one in melanocytic and non-melanocytic skin cancer
increases of 3-7% recorded in most white popula- (Armstrong, 1988; Kricker et al., 1994).
the last two or three decades (Armstrong, 1988). In conclusion, the present study documents in this Swiss
so support a few reports of increases in the mid- to population an approximately 2-fold increase of CMM, and
)s, which seemed unexpectedly large against the substantial increases also in non-melanocytic cancers over the
und of previous long-term trends (Burton and Arm- last two decades. The contribution of some increased surveil-
1994). The excision of skin lesions and laboratory lance on skin cancer is probably not negligible, but the
is of pigmented lesions rose sharply in Switzerland in parallel increase in overall mortality rates from all skin
,nd half of the 1980s, following a national campaign cancers in both sexes combined suggests that the advances in
r on prevention and early detection of CMM (Bul- early and effective treatment are not keeping pace with the
al., 1992). Thus, advancement of the time of diag- substantial increase of incidence. The study and the
ts a likely explanation of the especially steep increase modification of lifestyle changes (i.e. UV exposure) that
4 incidence in 1986-90, and of the apparent plateau underlie the worldwide epidemic of skin neoplasms maintain,
-92. Such a sharp rise, apart from a very limited therefore, a high priority in the cancer agenda.
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